Craneware (CRW) Competitors

Craneware has a consensus price target of GBX 1,673.33, indicating a potential upside of 54.65%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than Instem.

In the previous week, Craneware had 3 more articles in the media than Instem. MarketBeat recorded 3 mentions for Craneware and 0 mentions for Instem. Instem's average media sentiment score of 0.00 beat Craneware's score of -0.04 indicating that Instem is being referred to more favorably in the media.

65.9% of Instem shares are owned by institutional investors. Comparatively, 33.6% of Craneware shares are owned by institutional investors. 30.0% of Instem shares are owned by insiders. Comparatively, 10.3% of Craneware shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Craneware has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Instem has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market. Comparatively, Craneware has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market.

Craneware has a net margin of 9.58% compared to Instem's net margin of 5.50%. Instem's return on equity of 6.35% beat Craneware's return on equity.

33.6% of Craneware shares are held by institutional investors. Comparatively, 21.0% of Kooth shares are held by institutional investors. 10.3% of Craneware shares are held by company insiders. Comparatively, 30.4% of Kooth shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Kooth had 1 more articles in the media than Craneware. MarketBeat recorded 4 mentions for Kooth and 3 mentions for Craneware. Kooth's average media sentiment score of 0.61 beat Craneware's score of -0.04 indicating that Kooth is being referred to more favorably in the news media.

Craneware has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market. Comparatively, Kooth has a beta of 1.317, suggesting that its stock price is 32% more volatile than the broader market.

Craneware has higher revenue and earnings than Kooth. Craneware is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Craneware currently has a consensus price target of GBX 1,673.33, suggesting a potential upside of 54.65%. Kooth has a consensus price target of GBX 345, suggesting a potential upside of 86.49%. Given Kooth's higher possible upside, analysts plainly believe Kooth is more favorable than Craneware.

Craneware has a net margin of 9.58% compared to Kooth's net margin of 9.43%. Kooth's return on equity of 17.74% beat Craneware's return on equity.

Craneware has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Craneware has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market. Comparatively, Renalytix has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market.

Craneware has a net margin of 9.58% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat Craneware's return on equity.

In the previous week, Craneware had 1 more articles in the media than Renalytix. MarketBeat recorded 3 mentions for Craneware and 2 mentions for Renalytix. Renalytix's average media sentiment score of 0.48 beat Craneware's score of -0.04 indicating that Renalytix is being referred to more favorably in the news media.

33.6% of Craneware shares are held by institutional investors. Comparatively, 14.0% of Renalytix shares are held by institutional investors. 10.3% of Craneware shares are held by insiders. Comparatively, 5.1% of Renalytix shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Craneware presently has a consensus target price of GBX 1,673.33, suggesting a potential upside of 54.65%. Given Craneware's stronger consensus rating and higher probable upside, research analysts clearly believe Craneware is more favorable than Renalytix.

Craneware has a net margin of 9.58% compared to Cambridge Cognition's net margin of -13.86%. Craneware's return on equity of 5.94% beat Cambridge Cognition's return on equity.

Craneware currently has a consensus price target of GBX 1,673.33, suggesting a potential upside of 54.65%. Cambridge Cognition has a consensus price target of GBX 56, suggesting a potential upside of 100.00%. Given Cambridge Cognition's higher possible upside, analysts plainly believe Cambridge Cognition is more favorable than Craneware.

Craneware has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.809, suggesting that its stock price is 19% less volatile than the broader market.

In the previous week, Craneware had 3 more articles in the media than Cambridge Cognition. MarketBeat recorded 3 mentions for Craneware and 0 mentions for Cambridge Cognition. Cambridge Cognition's average media sentiment score of 0.00 beat Craneware's score of -0.04 indicating that Cambridge Cognition is being referred to more favorably in the news media.

33.6% of Craneware shares are held by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are held by institutional investors. 10.3% of Craneware shares are held by company insiders. Comparatively, 3.2% of Cambridge Cognition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Craneware has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.